|
Search
Collections
Benchmarks
Upload document
Product
64Cu-DOTA-ECL1i
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Head and Neck Cancer
Clinical trial
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
Status: Terminated
, Estimated PCD: 2023-02-07
